Walgreens: Step two of the Alliance Boots transaction to begin in February 2015
LONDON — The U.K. daily the Telegraph on Monday reported conjecture that Walgreens may seek to pull the trigger on the second step in its acquisition of Alliance Boots sooner rather than later. According to the report, Walgreens could acquire the remaining stake in Alliance Boots in as little as eight months. Presently, Walgreens has an option to acquire the remaining stake in Alliance Boots beginning February 2015.
Walgreens currently holds a 45% stake in Alliance Boots.
According to the report, the deal would be accelerated in an effort to begin an inversion, relocating Walgreens headquarters from the Chicago area to overseas.
However, in an email to Drug Store News last week, Walgreens spokesman Michael Polzin said, "The window for step two of the [Alliance Boots] transaction begins in February 2015. The current agreement doesn’t allow for a move prior to that."
Regarding a possible inversion, Polzin said, "We regularly meet with our investors and always welcome their input. Over the past year, we have made significant progress in our strategic partnership with Alliance Boots as we move toward the window for exercising the second step of our transaction. Our focus is always on analyzing and doing what is in the best long-term interest of our company and its shareholders, and when we have something more definitive to announce about our future structure and strategies, we will do so."
ABC authorizes special $650 million share repurchase program
VALLEY FORGE, Pa. — AmerisourceBergen on Monday announced that its board of directors has authorized a special $650 million share repurchase program intended to supplement the company’s previously announced warrant hedging strategy. The special program will be used to mitigate the potentially dilutive effect on the ownership interests of its then-existing stockholders that may result from the issuance of common stock upon exercise of the warrants issued in March 2013.
As previously disclosed, subsidiaries of Walgreens and Alliance Boots were collectively issued warrants to purchase up to 22.7 million shares of the company’s common stock at an exercise price of $51.50 per share exercisable during a six month period beginning in March 2016 and warrants to purchase up to 22.7 million shares of the company’s common stock at an exercise price of $52.50 per share exercisable during a six-month period beginning in March 2017.
Once completed, the share repurchases under the special program, together with the issuer capped call option transactions described in the company’s form 10-Q for the fiscal quarter ended March 31, are expected to mitigate approximately 80% of the potentially dilutive effect that the issuance of shares of the company’s common stock upon exercise of the warrants could have. The company will continue to explore additional opportunities to mitigate any remaining potentially dilutive effect of the warrants.
Share repurchases under the special program are expected to take place over an extended period of time, subject to market conditions.